The RUNX1-EVI1 fusion occurs as a secondary mutation in patients suffering from CML in blast crisis,69 MDS and AML,70 and is associated with a poor outcome. The gene discussed is MECOM; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.